Oncolytic HSV-1716
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Oncolytic HSV-1716, covering 2016-05-30 to 2016-05-30. Get the full timeline:
Most recent: Clinical Trial Update: Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery [Phase 1]